Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00444_DB01211_nanopub.RAOmP0RMX27IKMKQFE_6JB0TB0hY6BAc9erzyEFjBZyEg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00444_DB01211 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00444_DB01211 label "DDI between Teniposide and Clarithromycin - The strong CYP3A4 inhibitor, Clarithromycin, may decrease the metabolism and clearance of Teniposide, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Teniposide if Clarithromycin is initiated, discontinued or dose changed. [drugbank_resource:DB00444_DB01211]" assertion.
- drugbank_resource:DB00444_DB01211 identifier "drugbank_resource:DB00444_DB01211" assertion.
- drugbank_resource:DB00444_DB01211 title "DDI between Teniposide and Clarithromycin - The strong CYP3A4 inhibitor, Clarithromycin, may decrease the metabolism and clearance of Teniposide, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Teniposide if Clarithromycin is initiated, discontinued or dose changed." assertion.
- drugbank:DB01211 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00444_DB01211 assertion.
- drugbank:DB00444 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00444_DB01211 assertion.